Problem Definition
Savoro Foods is a privately owned frozen-food manufacturer based in Germany. It makes frozen ready meals (pasta dishes, curries, stews and oven bakes) in three plants and sells them to supermarkets in Germany, Austria and the Netherlands. Savoro generates EUR 380M in revenue at an 11% EBITDA margin (approximately EUR 42M). About 60% of sales are under its own brand and 40% are private-label meals made for retailers. The frozen category has been kind to Savoro: German consumers are eating out less and cooking simple meals at home more, and frozen food sales in Germany grew again in 2025.
Savoro's CEO wants a second growth engine and believes plant-based food is it. A private equity fund has approached Savoro to sell Leafline Kitchen, a Dutch plant-based brand that makes meat-free burgers, mince, nuggets and a small range of frozen plant-based meals. Leafline had revenue of EUR 62M in 2025 and is sold in Dutch and German supermarkets and to foodservice customers. It does not own a factory: about 70% of its volume is made by a third-party co-packer. The fund bought Leafline in 2021, when plant-based meat was a hot category, and is asking EUR 110M.
The CEO likes the idea of owning a known plant-based brand. The CFO is worried: Leafline's sales have fallen for two years in a row, and she has read that plant-based meat sales are falling in several markets. The owners have asked your team for an independent view before the next board meeting.
Should Savoro Foods acquire Leafline Kitchen, and if so, what is the most it should pay?
Additional InformationAsk for dataInterviewer’s data
If asked, please share that:
- Savoro's three plants run at approximately 68% capacity utilisation. One plant has a line that could be converted to plant-based products for approximately EUR 5M.
- Savoro has EUR 30M of cash and could borrow up to 2.5x EBITDA (approximately EUR 105M)
- Leafline's 2025 channel mix: branded retail 55%, foodservice 30%, private label 15%
- Leafline has approximately 110 employees, including a 25-person sales and marketing team
- Savoro has never made an acquisition
Question 1Structuring
How would you structure your analysis of whether Savoro should buy Leafline?
Hint · Structuring
Build 3–4 branches that are specific to this client and question, not a generic framework. Check they don't overlap and together cover the problem.
Try it first, then checkCheck my answerModel answer
A strong structure has four branches:
1. Is the plant-based meat market attractive?
- Size and growth of plant-based meat in Leafline's markets (Netherlands, Germany) vs. other categories
- Drivers and barriers: price gap vs. meat, taste, health perception
- Competitive structure: brands vs. private label, and who is winning
2. Is Leafline a good business?
- Revenue trend vs. the market: is it losing share or just following the category?
- Profitability: gross margin, EBITDA margin, co-packer dependence
- Brand strength, customer concentration, channel mix (retail, foodservice, private label)
3. What is it worth to Savoro specifically?
- Standalone value using benchmark multiples
- Cost synergies: moving production into Savoro's under-used plants, logistics, overheads
- Revenue synergies: plant-based versions of Savoro meals, cross-selling to Savoro's retailers
- One-off integration costs
4. Price, alternatives and risks
- Maximum price Savoro can pay while still creating value for its owners
- Alternatives: build its own range, partner or license, or do nothing
- Financing, integration risk (Savoro has never acquired), and downside if the category keeps shrinking
What the interviewer is looking forInterviewer’s viewInterviewer’s view
A good candidate covers the four classic deal questions: market attractiveness, target performance, synergies and fit, and valuation/price. A strong candidate makes them specific to this deal: whether the plant-based meat category is growing or shrinking, why Leafline is losing sales, whether Savoro's factories and retailer relationships create real synergies, and what the price implies. An excellent candidate also frames the alternatives: build a plant-based range organically, or partner, instead of buying. They also point out that the asking price must be tested against both standalone value and synergy value.
If the candidate starts with valuation, ask: "Before we get to price, what would you need to believe for this deal to make sense at all?"
Question 2Judgement & Insights
Here is some market data and Leafline's financial history. What do you conclude about the plant-based meat market and about Leafline?
Hint · Judgement & Insights
Read the exhibit title, axes and units first. Lead with the ‘so what’, then back it with one or two numbers.
Exhibit 1Market Indicators
| Indicator | Approximate value | Period |
|---|---|---|
| German frozen food market, all channels | EUR 23.6B, +4.5% | 2025 |
| German frozen food, retail channel | EUR 12.3B, +4.7% | 2025 |
| Frozen ready meals, German retail (volume growth) | +4.7% | 2025 |
| Plant-based food retail sales, Germany | EUR 1.7B, +3% | 2025 |
| Plant-based food retail sales, 6 largest European markets | EUR 4.75B, +3.3% | 2025 |
| Plant-based food retail sales, Netherlands | EUR 259M, −4% | 2025 |
| Share of UK plant-based sales that is private label | approx. 90% | 2025 |
| Plant-based meat price vs. animal meat: France / Spain | approx. +25% / approx. 2x | 2025 |
| Global plant-based meat retail sales | USD 6.6B, +8% (+4% after inflation) | 2025 |
| US plant-based meat and seafood retail sales | USD 1.0B, −10% | 2025 |
| Beyond Meat net revenue / gross margin | USD 275.5M, −15.6% / 2.8% | 2025 |
| Private investment in alternative proteins, global | USD 881M, −20% | 2025 |
Source: Savoro Foods case file
Exhibit 2Leafline Kitchen Financial History (EUR M)
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | 71 | 75 | 68 | 62 |
| Revenue growth | — | +5.6% | −9.3% | −8.8% |
| Gross margin | 31% | 29% | 27% | 26% |
| EBITDA | 5.7 | 5.3 | 4.0 | 3.0 |
| EBITDA margin | 8.0% | 7.1% | 5.9% | 4.8% |
| Share of revenue from private label | 6% | 8% | 11% | 15% |
Source: Savoro Foods case file
Additional InformationAsk for dataInterviewer’s data
Share Exhibits 1 and 2 together.
Try it first, then checkCheck my answerModel answer
Market conclusions
- Frozen is the stronger category. German frozen food grew approximately 4.5% in value in 2025 and frozen ready meals grew approximately 4.7% in volume in retail. Savoro's core business is in a healthy market.
- European plant-based is flat, not dead. Retail sales in the six largest markets grew approximately 3%, Germany +3%, while the Netherlands fell 4%. Global plant-based meat grew only approximately 4% after inflation.
- Downside risk is real. US plant-based meat fell 10% in 2025, Beyond Meat's revenue fell approximately 16% with a gross margin under 3%, and investors have pulled back (funding −20%).
- Price is the barrier, and private label is the winner. Plant-based meat still costs approximately 25% more than meat in France and about twice as much in Spain. In the UK approximately 90% of plant-based sales are private label.
Leafline conclusions
- Revenue down 17% from its 2023 peak (75 → 62), while its main markets were roughly flat: Leafline is losing share.
- Gross margin down 5 points (31% → 26%) and EBITDA margin down by 40% (8.0% → 4.8%). Prices are under pressure and fixed costs are spread over less volume.
- Private label share up from 6% to 15%. Leafline is filling its co-packer with lower-margin work, so the brand is weakening.
Implication for Savoro: The asset is a declining brand in a flat category. Any value must come mainly from what Savoro can do with the volume (make it cheaper in its own plants, sell it through its retailer relationships), not from the brand's growth.
What the interviewer is looking forInterviewer’s viewInterviewer’s view
A good candidate reads the main trends: frozen food is growing, plant-based is roughly flat to slightly growing in Europe, and Leafline is shrinking with falling margins. A strong candidate compares Leafline's −9% with its markets (Germany +3%, Netherlands −4%) and concludes that Leafline is losing share, not just suffering from a weak category. They link this to private label and price: branded plant-based meat costs 25% to 100% more than meat, shoppers are moving to cheaper own-label products, and Leafline is itself shifting into lower-margin private label. An excellent candidate turns this around: Savoro's strengths (low-cost frozen manufacturing and a 40% private-label business) are exactly what is winning in this category. That questions why Savoro needs to pay for a brand at all.
Apply the "So What?" cascade when evaluating answers:
- Level 1 (surface): "Leafline's revenue fell 17% in two years and its EBITDA margin fell by 40% (8.0% to 4.8%)."
- Level 2 (implication): "The European plant-based market is not collapsing (Germany +3%), so Leafline is losing share, most likely to cheaper private label. The US numbers and Beyond Meat show how bad the downside for brands can be."
- Level 3 (actionable): "The value in this category is moving from brands to low-cost manufacturing and private label, which Savoro already has. Savoro should pay for Leafline's volume and distribution, not for a brand premium, and should compare the deal with building its own range."
Question 3Numeracy
The seller is asking EUR 110M. Using the benchmarks below and Leafline's 2025 figures, what is Leafline worth on a standalone basis, and what multiples does the asking price imply?
Hint · Numeracy
Write the formula before you plug in numbers, keep units and zeros explicit, and sanity-check the order of magnitude at the end.
Additional InformationAsk for dataInterviewer’s data
Share these valuation benchmarks (median multiples for reported food and consumer deals in 2025):
| Buyer type | EV / EBITDA | EV / Revenue |
|---|---|---|
| Strategic buyers | 8.5x | 1.1x |
| Private equity buyers | 10.8x | 0.8x |
For reference, JBS bought the Dutch plant-based company Vivera in 2021 at a valuation of approximately EUR 431M, at the height of the category's popularity. Vivera then bought The Vegetarian Butcher from Unilever in 2025 for an undisclosed price, as Unilever cleared smaller brands out of its portfolio.
Try it first, then checkCheck my answerModel answer
Implied multiples of the asking price
- EV / EBITDA: EUR 110M / EUR 3.0M = approx. 36.7x, more than four times the 8.5x strategic median
- EV / Revenue: EUR 110M / EUR 62M = approx. 1.77x, about 60% above the 1.1x strategic median
Standalone value
- EBITDA method: 8.5 × EUR 3.0M = EUR 25.5M
- Revenue method: 1.1 × EUR 62M = EUR 68.2M
| Method | Standalone value (EUR M) | Asking price (EUR M) | Gap (EUR M) |
|---|---|---|---|
| EV / EBITDA (8.5x) | 25.5 | 110 | 84.5 |
| EV / Revenue (1.1x) | 68.2 | 110 | 41.8 |
Which method? The revenue multiple assumes Leafline makes a normal margin for the sector. It makes less than half of Savoro's margin (4.8% vs. 11%) and the margin is falling, so the EBITDA method (approx. EUR 25M) is the better guide. The revenue value is best seen as a ceiling, reached only if a buyer could lift Leafline's margin to a normal level.
Downside check: If revenue falls another 9% in 2026 to approximately EUR 56M and the margin stays at 4.8%, EBITDA would be approximately EUR 2.7M (56 × 4.8% = 2.69), worth approximately EUR 23M at 8.5x.
Conclusion: At EUR 110M, Savoro would be paying approximately EUR 85M more than the standalone value. The deal can only work if synergies are large, and even then Savoro should not pay all of that synergy value to the seller.
What the interviewer is looking forInterviewer’s viewInterviewer’s view
A good candidate calculates the implied multiples and the standalone value. A strong candidate notices the large gap between the EBITDA-based value (approx. EUR 25.5M) and the revenue-based value (approx. EUR 68M), and explains why the EBITDA method is more relevant for a shrinking, low-margin business. An excellent candidate adds that the 2025 EBITDA may itself be too high if the decline continues, and that the seller's price probably reflects its 2021 entry valuation, not today's market.
Question 4Numeracy
Savoro's operations team has estimated the synergies in Exhibit 3. What is the maximum price Savoro should pay, assuming it is willing to share half of the net synergy value with the seller?
Hint · Numeracy
Write the formula before you plug in numbers, keep units and zeros explicit, and sanity-check the order of magnitude at the end.
Exhibit 3Estimated Synergies (Run-Rate, Year 3)
| Synergy | Description | Annual EBITDA impact (EUR M) |
|---|---|---|
| Manufacturing | Move co-packed volume into Savoro's under-used plant (co-packer fee EUR 10M a year vs. approx. EUR 6M own cost) | 4.0 |
| Logistics | Shared frozen warehousing and delivery to the same retailers | 1.9 |
| SG&A | Merge back office and part of the sales team (approx. 35% of Leafline's approx. EUR 13M SG&A) | 4.5 |
| Revenue | Plant-based versions of Savoro's top 10 meals: EUR 15M revenue at 30% contribution margin (EUR 4.5M), 50% probability | 2.25 (risk-weighted) |
| One-off costs | Line conversion EUR 5M + integration EUR 4M | 9.0 (one-off) |
Source: Savoro Foods case file
Additional InformationAsk for dataInterviewer’s data
- Value synergies at the same 8.5x EBITDA multiple
- Synergies reach the full run-rate in year 3; for this exercise, ignore the ramp-up and discounting
- One-off costs are paid once and reduce the value of the synergies
Try it first, then checkCheck my answerModel answer
Step 1: Total annual synergies
- Cost synergies: 4.0 + 1.9 + 4.5 = EUR 10.4M
- Revenue synergy (risk-weighted): EUR 4.5M × 50% = EUR 2.25M
- Total: 10.4 + 2.25 = EUR 12.65M per year
Step 2: Value of synergies
- Gross value: 8.5 × EUR 12.65M = EUR 107.525M (approx. EUR 107.5M)
- Less one-off costs: 107.525 − 9.0 = EUR 98.525M net (approx. EUR 98.5M)
Step 3: Maximum price
- Savoro shares half with the seller: 98.525 × 50% = EUR 49.26M
- Plus standalone value (EBITDA method): EUR 25.5M
- Maximum price: 25.5 + 49.26 = approx. EUR 74.8M, so about EUR 75M
Step 4: What EUR 110M would mean
- Premium over standalone: 110 − 25.5 = EUR 84.5M
- Share of net synergy value given to the seller: 84.5 / 98.525 = approx. 86%
- Savoro would carry all of the integration risk and keep only approx. 14% of the upside.
| EUR M | |
|---|---|
| Standalone value | 25.5 |
| Net synergy value | 98.5 |
| Value to Savoro with all synergies | 124.0 |
| Walk-away price (50% of synergies shared) | approx. 75 |
| Asking price | 110 |
Quality of synergies: About 82% of the annual synergies (10.4 / 12.65) are cost synergies, which Savoro controls. But the biggest one, manufacturing, depends on Leafline's volume. If Leafline keeps losing 9% of revenue a year, that synergy shrinks too. The revenue synergy is the least certain part.
What the interviewer is looking forInterviewer’s viewInterviewer’s view
A good candidate adds up the synergies and values them. A strong candidate subtracts the one-off costs, applies the 50% share and adds the standalone value to get a walk-away price of approximately EUR 75M. An excellent candidate works out how much of the synergy value Savoro would have to give away to justify EUR 110M (approx. 86%). They also note that the cost synergies (EUR 10.4M) are more certain than the revenue synergy, and that the manufacturing synergy depends on Leafline's volume not shrinking further.
Question 5Synthesis
The owners of Savoro want a clear answer. What do you recommend?
Hint · Synthesis
Answer first: the recommendation, two or three reasons with numbers, then risks and next steps.
Additional InformationAsk for dataInterviewer’s data
If the candidate asks about alternatives, share that:
- Building its own plant-based frozen range would cost Savoro approximately EUR 8M over two years (recipe development, line conversion, listing fees)
- Savoro estimates the organic range could reach EUR 20M in revenue by year 3, mostly private label, at an 8% EBITDA margin
Try it first, then checkCheck my answerModel answer
Recommendation: Savoro should not buy Leafline at EUR 110M. It should offer up to approximately EUR 75M, with part of it paid only if Leafline's sales stabilise. If the seller refuses, Savoro should build its own plant-based range.
Why:
- The price is far above standalone value. EUR 110M is approximately 37x EBITDA against an 8.5x median for strategic food deals. Leafline is worth approximately EUR 25M on its own.
- Synergies are real but do not justify EUR 110M. Net synergy value is approximately EUR 98.5M. Paying EUR 110M hands approximately 86% of it to the seller, while Savoro carries all of the integration risk.
- The category rewards low-cost manufacturing, not brands. European plant-based sales are roughly flat (+3%), shoppers are moving to private label, and Leafline is losing share. Savoro already has the capabilities that are winning.
Buy vs. build (return on capital):
| Option | Capital (EUR M) | Year-3 EBITDA (EUR M) | Return on capital |
|---|---|---|---|
| Buy at EUR 110M | 110 + 9 = 119 | 3.0 + 12.65 = 15.65 | approx. 13% |
| Buy at EUR 75M | 75 + 9 = 84 | 15.65 | approx. 19% |
| Build organically | 8 | 20 × 8% = 1.6 | 20% |
Buying at approximately EUR 75M gives a similar return to building, but with ten times the scale and a two-to-three-year head start. At EUR 110M it is clearly worse.
Proposed offer: EUR 60M upfront, plus an earn-out of up to EUR 15M if Leafline's 2027 revenue is at least EUR 62M (the 2025 level). This protects Savoro if the decline continues and rewards the seller if the brand recovers.
Risks and mitigations:
- Leafline keeps losing share: the earn-out protects the price; move production in-house fast to lock in the EUR 4M manufacturing synergy
- Savoro has never integrated an acquisition: appoint a dedicated integration lead and keep Leafline's brand and key sales staff for 12–18 months
- Debt: EUR 60M upfront is within Savoro's borrowing capacity (approx. EUR 105M) plus cash (EUR 30M)
Next steps:
- Make a non-binding offer of EUR 60M + EUR 15M earn-out (Week 1–2)
- Due diligence on Leafline's 2026 trading, co-packer contract exit terms and retailer listings (Weeks 2–8)
- Prepare the build plan in parallel as the fallback if the seller will not come below EUR 75M
What the interviewer is looking forInterviewer’s viewInterviewer’s view
Look for a clear answer first: do not buy at EUR 110M. A strong candidate gives a walk-away price with a deal structure that shares risk (for example, an earn-out) and compares the deal with building. An excellent candidate shows that buying at the right price and building give similar returns on capital, then chooses based on speed and risk, and lays out next steps.
Data Sources
Company figures for Savoro Foods and Leafline Kitchen (revenue, margins, synergies, asking price) are fictional. Market facts come from these public sources (numbers rounded for interview math):
| Fact used in the case | Source |
|---|---|
| German frozen food sales approx. EUR 23.6B (+4.5%) in 2025; retail channel approx. EUR 12.3B (+4.7%); ready meals +4.7% in retail; consumers eating more at home | Deutsches Tiefkühlinstitut (dti), "dti-Absatzstatistik 2025: Tiefkühlkost weiter auf Wachstumskurs", 2026, https://www.presseportal.de/pm/53417/6261194 |
| Plant-based retail sales in the 6 largest European markets approx. EUR 4.75B (+3.3%); Germany approx. EUR 1.7B (+3%); Netherlands approx. EUR 259M (−4%) in 2025 | Green Queen (reporting GFI Europe / Circana data), "European Plant-Based Sales Grow By 3% As Price Gap with Meat & Dairy Narrows", 2026, https://www.greenqueen.com.hk/europe-plant-based-sales-market-gfi-circana-2025-meat-dairy-vegan/ |
| UK: approx. 90% of plant-based sales are private label; France: plant-based meat approx. 25% dearer than animal protein; Spain: meat analogues approx. 2x the price of meat | Green Queen (GFI Europe / Circana), 2026, https://www.greenqueen.com.hk/europe-plant-based-sales-market-gfi-circana-2025-meat-dairy-vegan/ |
| Global plant-based meat retail sales approx. USD 6.6B (+8%, +4% after inflation); US plant-based meat and seafood approx. USD 1.0B (−10% in value, −11% in units); alternative protein funding USD 881M (−20%) in 2025 | Green Queen (reporting GFI State of the Industry), "Global Plant-Based Food Sales Grew by 3% in 2025: GFI Report", 2026, https://www.greenqueen.com.hk/gfi-state-of-the-industry-report-2025-2026-plant-based-sales/ |
| Beyond Meat 2025 net revenue USD 275.5M (−15.6%), gross margin 2.8% | WATTPoultry, "Beyond Meat posts record-low revenue, deep operating losses in 2025", 2026, https://www.wattagnet.com/poultry-future/consumer-trends/alternative-protiens/news/15821103/beyond-meat-posts-recordlow-revenue-deep-operating-losses-in-2025 (company results: https://investors.beyondmeat.com/news-releases/news-release-details/beyond-meatr-reports-fourth-quarter-and-full-year-2025-financial) |
| Median EV/EBITDA for 2025 food and consumer deals: 8.5x strategic, 10.8x private equity; median EV/Revenue: 1.1x strategic, 0.8x private equity | R.L. Hulett, "Food & Consumer M&A Update Q4 2025", 2026, https://rlhulett.com/app/uploads/2026/01/Food-Consumer-MA-Update-Q4-2025.pdf |
| JBS bought Vivera in 2021 in a deal that valued it at approx. EUR 431M | FoodNavigator, "Meat juggernaut JBS launches new plant-based company", 2025, https://www.foodnavigator.com/Article/2025/09/02/jbs-launches-the-vegetarian-butcher-collective/ |
| Unilever sold The Vegetarian Butcher to Vivera in 2025 for an undisclosed price | Unilever, "Unilever to sell The Vegetarian Butcher to Vivera", 2025, https://www.unilever.com/news/press-and-media/press-releases/2025/unilever-to-sell-the-vegetarian-butcher-to-vivera/ ; Green Queen, "Why Unilever is Selling The Vegetarian Butcher to JBS-Owned Vivera", 2025, https://www.greenqueen.com.hk/unilever-the-vegetarian-butcher-plant-based-meat-sale-jbs-vivera/ |
Free in the DrillCase case library · Editorial policy